AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle
- PMID: 15877046
- DOI: 10.1038/sj.gt.3302546
AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle
Abstract
Replicating adenoviral vectors (RAds) hold great promise for the treatment of cancer. Significant therapeutic effects of these vectors do not only rely on tumor targeting but also on efficient release of viral progeny from host cells. Cytotoxic genes expressed late in the adenoviral life cycle can significantly enhance viral release and spreading. Therefore, an adenoviral cloning system that allows easy integration of established tumor targeting techniques together with late expression of transgenes can be a valuable tool for the development of RAds. We expanded the features of the widely used AdEasy adenoviral cloning system toward the production of tropism modified replicating adenoviral vectors that express transgenes late in the viral life cycle. Three vectors (pIRES, pFIBER and pAdEasy-Sce) that facilitate easy manipulation of the adenoviral fiber region were established. Unique BstBI and I-Sce-1 restriction sites facilitate the introduction of retargeting peptides in the fiber HI-loop and of genes of interest in the fiber transcription unit. We validated the system by constructing an E1-positive adenovirus with an RGD motif in the fiber HI-loop and green fluorescent protein (GFP) expressed from the fiber transcription unit (AdDelta24Fiber-rgd-GFP). Additionally, assessment of E1-negative replication-deficient vectors confirmed strict dependence upon E1 expression for the expression of transgenes inserted into the fiber transcription unit. This flexible cloning system allows for straightforward construction of tropism expanded replicating adenoviral vectors that express transgenes late in the adenoviral life cycle.
Similar articles
-
Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.Hum Gene Ther. 2003 Mar 1;14(4):329-39. doi: 10.1089/104303403321208934. Hum Gene Ther. 2003. PMID: 12659674
-
Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.Hum Gene Ther. 2002 Oct 10;13(15):1859-71. doi: 10.1089/104303402760372954. Hum Gene Ther. 2002. PMID: 12396618
-
Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.J Gene Med. 2003 Apr;5(4):267-76. doi: 10.1002/jgm.348. J Gene Med. 2003. PMID: 12692861
-
Modified adenoviruses for cancer gene therapy.Int J Cancer. 2004 Jul 1;110(4):475-80. doi: 10.1002/ijc.20129. Int J Cancer. 2004. PMID: 15122578 Review.
-
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.Viruses. 2021 Dec 14;13(12):2502. doi: 10.3390/v13122502. Viruses. 2021. PMID: 34960772 Free PMC article. Review.
Cited by
-
Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications.Front Med Technol. 2023 Jan 26;5:1095198. doi: 10.3389/fmedt.2023.1095198. eCollection 2023. Front Med Technol. 2023. PMID: 36776626 Free PMC article.
-
A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.Prostate. 2014 Sep;74(13):1286-1296. doi: 10.1002/pros.22845. Epub 2014 Jul 25. Prostate. 2014. PMID: 25065656 Free PMC article.
-
A novel method for generating and screening peptides and libraries displayed on adenovirus fiber.Nucleic Acids Res. 2007;35(20):e138. doi: 10.1093/nar/gkm914. Epub 2007 Oct 26. Nucleic Acids Res. 2007. PMID: 17965092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical